Investors & Media - BrainStorm Cell Therapeutics

News

Press Releases

Month Year

Investor Alerts

Dec 15, 2014

BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that wholly-owned subsidiary Brainstorm Cell...
- Photos 1
Nov 13, 2014

BrainStorm Announces Financial Results for the Third Quarter of 2014 and Provides Corporate Update

Conference call today at 8.30 AM EST

BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced financial results for the three and nine months ending...
- Photos 1
Nov 5, 2014

BrainStorm Cell Therapeutics to Report Third Quarter 2014 Financial Results on Thursday, November 13

BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it will report third quarter 2014 financial...
Oct 7, 2014

FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALS

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the United States Food and Drug...
- Photos 1
Oct 6, 2014

BrainStorm Reports Last Patient Visit in Phase 2a ALS Study

BrainStorm Cell Therapeutics (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the last patient has completed the last visit...